Tweet out to the columnist/ contributors of the ar
Post# of 148183
(Total Views: 452)
Posted On: 03/10/2020 5:40:16 PM
Tweet out to the columnist/ contributors of the articles about Cytodyn and how our drug targets ccr5 receptors. I mentioned our successful combo trial too. If everyone tweets then maybe someone will run with it. Below is what I tweeted to Gina Yu of cnn.
"Great article on role of CCR5. FYI - there is a biotech called Cytodyn that has just finished phase 3 trial for HIV in combo with HAART with meeting 81% of their endpoint goals with no side effects. "
"Great article on role of CCR5. FYI - there is a biotech called Cytodyn that has just finished phase 3 trial for HIV in combo with HAART with meeting 81% of their endpoint goals with no side effects. "
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼